Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trial
- 31 July 1996
- Vol. 48 (1) , 21-27
- https://doi.org/10.1016/s0090-4295(96)90059-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cancer statistics, 1995CA: A Cancer Journal for Clinicians, 1995
- Durability of the Tumor-Free Response for Intravesical Bacillus Calmette-Guerin TherapyJournal of Urology, 1994
- Dose-Response of Bacillus Calmette-Guerin in the Treatment of Superficial Bladder CancerJournal of Urology, 1992
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1991
- Biology and Management of Bladder CancerNew England Journal of Medicine, 1990
- Long-Term Results of Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder CancerJournal of Urology, 1989
- A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer.Journal of Clinical Oncology, 1987
- Risks and Benefits of Repeated Courses of Intravesical Bacillus Calmette-guerin Therapy for Superficial Bladder CancerJournal of Urology, 1987
- Non-Invasive Papillary Carcinoma of the Bladder Associated with Carcinoma in SituJournal of Urology, 1976
- Infiltrating Carcinoma of the Bladder: Relation of Depth of Penetration of the Bladder Wall to Incidence of Local Extension and MetastasesJournal of Urology, 1946